CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | Krishnan Suma President, R&D | Option exercise · Performance Stock Units | −7,500 | 7,500 | ||
| 2024-02-28 | Krishnan Krish S President and CEO | Option exercise | +12,500 | 1,643,047 | ||
| 2024-02-28 | Krishnan Krish S President and CEO | Shares withheld for taxes | −5,785 | $163.08 | $943K | 1,637,262 |
| 2024-02-28 | Krishnan Krish S President and CEO | Option exercise | +7,500 | 1,579,353 | ||
| 2024-02-28 | Krishnan Krish S President and CEO | Shares withheld for taxes | −3,471 | $163.08 | $566K | 1,575,882 |
| 2024-02-28 | Krishnan Krish S President and CEO | Option exercise · Performance Stock Units | −12,500 | 12,500 | ||
| 2024-02-27 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +1,913 | $52.26 | $100K | 12,936 |
| 2024-02-27 | ROMANO KATHRYN Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,913 | 0 | ||
| 2024-02-26 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $52.26 | $261K | 17,556 |
| 2024-02-26 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −5,000 | $135.00 | $675K | 12,556 |
| 2024-02-26 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +3,087 | $52.26 | $161K | 15,643 |
| 2024-02-26 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −3,087 | $140.00 | $432K | 12,556 |
| 2024-02-26 | ROMANO KATHRYN Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −1,533 | $157.00 | $241K | 11,023 |
| 2024-02-26 | ROMANO KATHRYN Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 5,000 | ||
| 2024-02-26 | ROMANO KATHRYN Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,087 | 1,913 | ||
| 2024-02-26 | Krishnan Suma President, R&D | Shares withheld for taxes | −2,353 | $157.00 | $369K | 1,571,853 |
| 2024-02-26 | Krishnan Krish S President and CEO | Shares withheld for taxes | −3,791 | $157.00 | $595K | 1,630,547 |
| 2024-01-22 | Romano Kathryn Chief Accounting Officer | Option exercise 10b5-1 | +2,500 | $52.26 | $131K | 15,056 |
| 2024-01-22 | Romano Kathryn Chief Accounting Officer | Sale 10b5-1 | −2,500 | $130.00 | $325K | 12,556 |
| 2024-01-22 | Romano Kathryn Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 10,000 |
Page 26 of 42 · 828 trades